German American Bancorp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-39,669
Closed -$2.56M 95
2021
Q1
$2.56M Buy
39,669
+7,676
+24% +$495K 0.44% 44
2020
Q4
$1.86M Sell
31,993
-3,595
-10% -$217K 0.37% 44
2020
Q3
$2.25M Buy
35,588
+520
+1% +$36.1K 0.55% 41
2020
Q2
$2.7M Sell
35,068
-30,173
-46% -$2.31M 0.71% 39
2020
Q1
$4.88M Buy
65,241
+23,361
+56% +$1.61M 1.44% 17
2019
Q4
$2.72M Sell
41,880
-20,814
-33% -$1.36M 0.67% 40
2019
Q3
$3.97M Sell
62,694
-2,546
-4% -$166K 1.06% 26
2019
Q2
$4.41M Buy
65,240
+3,180
+5% +$209K 1.2% 23
2019
Q1
$4.03M Buy
62,060
+1,974
+3% +$131K 1.19% 24
2018
Q4
$3.76M Buy
60,086
+1,874
+3% +$131K 1.25% 19
2018
Q3
$4.5M Buy
58,212
+251
+0.4% +$19K 1.35% 19
2018
Q2
$4.11M Buy
+57,961
New +$4.09M 1.29% 19

Other funds holding GILD

German American Bancorp's GILD Position: Q2 2021 in Review

German American Bancorp sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 39,669 shares — an estimated $2.56M sold.

German American Bancorp first reported a position in GILD in Q2 2018 and held it in 12 quarters. The position peaked at $4.88M in Q1 2020. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • German American Bancorp reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • German American Bancorp sold 39,669 Gilead Sciences shares in Q2 2021, an estimated $2.56M.
  • German American Bancorp first reported a position in Gilead Sciences in Q2 2018 and held it in 12 quarters.
  • German American Bancorp's Gilead Sciences position peaked at $4.88M in Q1 2020.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on German American Bancorp's 13F filing for Q2 2021, filed 13 Aug 2021.